These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33045420)
1. Proper definition of the set of autoantibody-targeted antigens relies on appropriate reference group selection. Moritz CP; Stoevesandt O; Tholance Y; Camdessanché JP; Antoine JC N Biotechnol; 2021 Jan; 60():168-172. PubMed ID: 33045420 [TBL] [Abstract][Full Text] [Related]
2. CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach. Moritz CP; Tholance Y; Stoevesandt O; Ferraud K; Camdessanché JP; Antoine JC Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33408168 [TBL] [Abstract][Full Text] [Related]
3. Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique. Moritz CP; Tholance Y; Rosier C; Reynaud-Federspiel E; Svahn J; Camdessanché JP; Antoine JC Proteomics Clin Appl; 2019 Jul; 13(4):e1800157. PubMed ID: 30768763 [TBL] [Abstract][Full Text] [Related]
4. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP). Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477 [TBL] [Abstract][Full Text] [Related]
6. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies. Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286 [TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. Sanvito L; Makowska A; Mahdi-Rogers M; Hadden RD; Peakman M; Gregson N; Nemni R; Hughes RA J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):333-8. PubMed ID: 19015227 [TBL] [Abstract][Full Text] [Related]
8. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China. Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967 [TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy. Beppu M; Sawai S; Satoh M; Mori M; Kazami T; Misawa S; Shibuya K; Ishibashi M; Sogawa K; Kado S; Kodera Y; Nomura F; Kuwabara S J Neuroimmunol; 2015 Oct; 287():9-15. PubMed ID: 26439954 [TBL] [Abstract][Full Text] [Related]
10. Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus. Zhu H; Luo H; Yan M; Zuo X; Li QZ Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):210-8. PubMed ID: 26415621 [TBL] [Abstract][Full Text] [Related]
11. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy. Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739 [TBL] [Abstract][Full Text] [Related]
12. Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. Moritz CP; Paul S; Stoevesandt O; Tholance Y; Camdessanché JP; Antoine JC Autoimmun Rev; 2020 Feb; 19(2):102450. PubMed ID: 31838165 [TBL] [Abstract][Full Text] [Related]